Labour
Conditions
Interventions
Normal saline
Metoclopramide
Sponsors
Jos University teaching Hospital
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Primigravidae at term with singleton pregnancy 2. Primigravidae at term with spontaneous onset of labour and foetus in longitudinal lie and cephalic presentation 3. Primigravidae at term with cervical os dilatation of 4cm 4. Primigravidae meeting the above criteria who give consent to be included in the study
Exclusion criteria
Exclusion criteria: 1. Women who have had a previous delivery 2. Women who have progressed beyond 4cm cervical os dilatation 3. Women with any contraindication to vaginal delivery 4. Women with abnormal presentations, multiple pregnancies, cephalo-pelvic disproportion, maternal obesity, short stature or medical disorder in pregnancy 5. Women with previous uterine scars 6. Women with previous adverse drug reaction to metoclopramide or with contraindication to metoclopramide 7. Women taking medications with drug interaction to metoclopramide 8. Women presenting preterm in labour
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome measures will include the total duration of the first, second and third stages of labor and cervical dilatation rate | — |
Secondary
| Measure | Time frame |
|---|---|
| Need for oxytocin augmentation, delivery route, clinical maternal side effects (particularly tardive dyskinesia, drowsiness, restlessness, breast enlargement, low mood, diarrhoea, and urinary incontinence), perineal tears and postpartum blood loss. Other secondary outcomes include APGAR scores at minute one and five after birth as well as neonatal intensive care unit admission rates. | — |
Countries
Nigeria
Contacts
Public ContactCharles Anyaka
Consultant Obstetrician and Gynecologist
Outcome results
None listed